Global Finasteride Market Size To Exceed USD 129.67 Million By 2033 | CAGR Of 2.40%
Category: HealthcareGlobal Finasteride Market Size To Exceed USD 129.67 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Finasteride Market Size Expected to Grow from USD 102.28 Million in 2023 to USD 129.67 Million by 2033, at a CAGR of 2.40% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 190 pages with 160 Market data tables and figures & charts from the report on the "Global Finasteride Market Size, Share, and COVID-19 Impact Analysis, By Product (1mg, 5mg), By Application (Prostate Enlargement, Prostate Cancer, Scalp Hair Loss, Excessive Hair Growth, Hormone Therapy), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/finasteride-market
The finasteride market refers to the worldwide demand for finasteride drugs primarily used in treating male hair loss and signs of benign prostatic hyperplasia in older men. This drug works through the inhibition of the enzyme 5-alpha-reductase that converts testosterone into the hormone dihydrotestosterone, which is a hormone responsible for affecting male hair loss and prostate growth. Demand in the finasteride market is rising in line with greater consumer focus on aesthetic treatments where prevention at the onset of hair loss is perceived by the younger generation as more important; improved patient profiling through personalized medicine leading to a demand for better physician advice; increased accessibility through over-the-counter finasteride coupled with permitting generic drugs. However, the corporation may face limits in the finasteride market due to side effects like as hormonal imbalances and reduced libido, which prevent certain users from using it.
The 1mg segment is expected to hold the largest share of the global finasteride market during the projected timeframe.
Based on product, the global finasteride market is categorized as 1mg and 5mg. Among these, the 1mg segment is expected to hold the largest share of the global finasteride market during the forecast period. This is because it is largely utilized in treating male pattern baldness, which crosses a broad demographic and continues to rise around the world.
The scalp hair loss segment is expected to grow at the fastest CAGR during the projected timeframe.
Based on the application, the global finasteride market is categorized as prostate enlargement, prostate cancer, scalp hair loss, excessive hair growth, and hormone therapy. Among these, the industrial furnace segment is expected to grow at the fastest CAGR during the projected timeframe. The scalp hair loss industry is expected to rise rapidly, driven by increased demand for non-invasive hair restoration procedures. Finasteride has been very beneficial in treating male pattern baldness.
The retail pharmacies segment is expected to hold the largest share of the global finasteride market during the projected timeframe.
Based on distribution channel, the global finasteride market is categorized as retail pharmacies, online pharmacies, and hospital pharmacies. Among these, the retail pharmacies segment is expected to hold the largest share of the global finasteride market during the projected timeframe. This supremacy is driven by widespread penetration and consumer trust in brick-and-mortar pharmacies for prescription drugs such as finasteride.
Asia Pacific is projected to hold the largest share of the global finasteride market over the forecast period.
Get more details on this report -
Asia Pacific is projected to hold the largest share of the global finasteride market over the forecast period. The growing number of patients with hair loss and prostate-related disorders, particularly in the world's two most populous countries, China and India, contributes to domination. Aside from this, rising awareness among patients about the availability of treatment alternatives, and substantial investments in the healthcare sector.
North America is expected to grow at the fastest CAGR growth of the global finasteride market during the forecast period. Male pattern baldness and prostate-related disorders are driving forces of progress due to their widespread prevalence, particularly in the United States. Major healthcare infrastructure, access to modern therapies, and consumer awareness are all major surmounting factors in this industry.
Major vendors in the global finasteride market are Accord Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Cipla, Merck, Mylan N.V., RelonChem, Sandoz, Topfond Pharmaceutical Co., Ltd., Dr Reddy's Laboratories Ltd., Novartis AG, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2023, Happy Head, a haircare and treatment company, launched its first all-in-one hair development pill, which includes Vitamin D, Minoxidil, and Finasteride.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global finasteride market based on the below-mentioned segments:
Global Finasteride Market, By Product
- 1mg
- 5mg
Global Finasteride Market, By Application
- Prostate Enlargement
- Prostate Cancer
- Scalp Hair Loss
- Excessive Hair Growth
- Hormone Therapy
Global Finasteride Market, By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Global Finasteride Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?